Alfred T. Harding

发表

ETV7 limits antiviral gene expression and control of SARS-CoV-2 and influenza viruses

N. Heaton, Heather M. Froggatt, Alfred T. Harding, 2019 .

Efforts to Improve the Seasonal Influenza Vaccine

N. Heaton, Alfred T. Harding, Nicholas S. Heaton, 2018, Vaccines.

Replication competent, 10-segmented influenza viruses as antiviral therapeutics

N. Heaton, Alfred T. Harding, Nicholas S. Heaton, 2019, bioRxiv.

The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection

N. Heaton, Alfred T. Harding, Nicholas S. Heaton, 2022, Cancers.

Influenza viruses that require 10 genomic segments as antiviral therapeutics

N. Heaton, Alfred T. Harding, Nicholas S. Heaton, 2019, PLoS pathogens.

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro

Jared L. Johnson, G. Getz, J. Blenis, 2020 .

SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2

N. Heaton, Alfred T. Harding, B. Heaton, 2020, bioRxiv.

ETV7 represses a subset of interferon-stimulated genes that restrict influenza viruses

N. Heaton, Heather M. Froggatt, Alfred T. Harding, 2019, bioRxiv.

Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs

N. Heaton, Alfred T. Harding, B. Heaton, 2017, mBio.

Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication

Jared L. Johnson, O. Elemento, J. Blenis, 2022, Science Signaling.

Rapid tissue prototyping with micro-organospheres

H. Clevers, W. Quayle, N. Heaton, 2022, Stem cell reports.

Control of antiviral innate immune response by protein geranylgeranylation

M. Glogauer, M. Bergo, D. Lacy, 2019, Science Advances.

A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice

N. Heaton, Alfred T. Harding, B. Heaton, 2022, Journal of virology.

Mechanisms of Neuroinvasion and Neuropathogenesis by Pathologic Flaviviruses

Alfred T. Harding, Liset de Vries, 2023, Viruses.

ETV7 limits antiviral gene expression and control of influenza viruses

N. Heaton, Heather M. Froggatt, Alfred T. Harding, 2021, Science Signaling.

A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor.

N. Heaton, D. Sachs, Alfred T. Harding, 2017, Cell reports.

GPER1 is required to protect fetal health from maternal inflammation

N. Heaton, Heather M. Froggatt, Alfred T. Harding, 2021, Science.

Single-cell genome-wide association reveals that a nonsynonymous variant in ERAP1 confers increased susceptibility to influenza virus

Dennis C. Ko, S. Gregory, N. Heaton, 2022, bioRxiv.

Influenza viral particles harboring the SARS-CoV-2 spike RBD as a combination respiratory disease vaccine

N. Heaton, Alfred T. Harding, B. Heaton, 2021, bioRxiv.